创新药出海持续提速!板块进入系统性估值修复阶段

银华基金
Yesterday

我国创新药“出海”通过三种形式,在全球医药产业链中从“跟跑”转向“并跑”,甚至在某些领域实现“领跑”。随着国产创新药出海、AI赋能创新药研发、商业健康保险逐步完善的创新药利好浪潮,头部企业迈入盈利阶段,创新药板块进入系统性估值修复阶段。5月20日,港股创新药企三生制药宣布,与国际大药企辉瑞签署协议,向辉瑞独家授予公司自主研发的双抗在全球(不包括中国内地)的开发、生产、商业化权利。根据协议,三生制药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10